The effects of a MAP2K5 microRNA target site SNP on risk for anxiety and depressive disorders

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 165, Issue 2, 2014, Pages 175-183

  Jensen, Kevin P ^a,b   Kranzler, Henry R ^c   Stein, Murray B ^d   Gelernter, Joel ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CT Healthcare Center   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Depression; GWAS; MEK5; MiR 330; Restless legs syndrome

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 330 3P; MITOGEN ACTIVATED PROTEIN KINASE KINASE 5; UNCLASSIFIED DRUG;

AGORAPHOBIA; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DRUG DEPENDENCE; GENE; GENE FREQUENCY; GENETIC TRAIT; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; PANIC; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; REGULATORY MECHANISM; RESTLESS LEGS SYNDROME; SINGLE NUCLEOTIDE POLYMORPHISM;

DEPRESSION; GWAS; MEK5; MIR-330; RESTLESS LEGS SYNDROME;

ANXIETY DISORDERS; DEPRESSIVE DISORDER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MAP KINASE KINASE 5; MICRORNAS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK;

EID: 84893795698     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32219     Document Type: Article

References (63)

1. Abelson JF, Kwan KY, O'Roak BJ, Baek DY, Stillman AA, Morgan TM, Mathews CA, Pauls DL, Rasin MR, Gunel M, Davis NR, Ercan-Sencicek AG, Guez DH, Spertus JA, Leckman JF, Dure LSt, Kurlan R, Singer HS, Gilbert DL, Farhi A, Louvi A, Lifton RP, Sestan N, State MW. 2005. Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 310(5746):317-320.
2. Andrews G, Stewart G, Allen R, Henderson AS. 1990. The genetics of six neurotic disorders: A twin study. J Affect Disord 19(1):23-29.
3. Asnaani A, Richey JA, Dimaite R, Hinton DE, Hofmann SG. 2010. A cross-ethnic comparison of lifetime prevalence rates of anxiety disorders. J Nerv Ment Dis 198(8):551-555.
4. Bartel DP. 2009. MicroRNAs: Target recognition and regulatory functions. Cell 136(2):215-233.
5. Bazzini AA, Lee MT, Giraldez AJ. 2012. Ribosome profiling shows that miR-430 reduces translation before causing mRNA decay in zebrafish. Science 336(6078):233-237.
6. Brest P, Lapaquette P, Souidi M, Lebrigand K, Cesaro A, Vouret-Craviari V, Mari B, Barbry P, Mosnier JF, Hebuterne X, Harel-Bellan A, Mograbi B, Darfeuille-Michaud A, Hofman P. 2011. A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease. Nat Genet 43(3):242-245.
7. Cross-Disorder Group of the Psychiatric Genomics C and Genetic Risk Outcome of Psychosis C. 2013. Identification of risk loci with shared effects on five major psychiatric disorders: A genome-wide analysis. Lancet 381(9875):1371-1379.
8. Chen K, Rajewsky N. 2006. Natural selection on human microRNA binding sites inferred from SNP data. Nat Genet 38(12):1452-1456.
9. Conner TS, Jensen KP, Tennen H, Furneaux HM, Kranzler HR, Covault J. 2010. Functional polymorphisms in the serotonin 1B receptor gene (HTR1B) predict self-reported anger and hostility among young men. Am J Med Genet Part B 153B(1):67-78.
10. Di Benedetto B, Hitz C, Holter SM, Kuhn R, Vogt Weisenhorn DM, Wurst W. 2007. Differential mRNA distribution of components of the ERK/MAPK signalling cascade in the adult mouse brain. J Comp Neurol 500(3):542-556.
11. Dreszer TR, Karolchik D, Zweig AS, Hinrichs AS, Raney BJ, Kuhn RM, Meyer LR, Wong M, Sloan CA, Rosenbloom KR, Roe G, Rhead B, Pohl A, Malladi VS, Li CH, Learned K, Kirkup V, Hsu F, Harte RA, Guruvadoo L, Goldman M, Giardine BM, Fujita PA, Diekhans M, Cline MS, Clawson H, Barber GP, Haussler D, James Kent W. 2012. The UCSC genome browser database: Extensions and updates 2011. Nucleic Acids Res 40(database issue):D918-D923.
12. Eichler EE, Flint J, Gibson G, Kong A, Leal SM, Moore JH, Nadeau JH. 2010. Missing heritability and strategies for finding the underlying causes of complex disease. Nat Rev Genet 11(6):446-450.
13. Ekins S, Bugrim A, Brovold L, Kirillov E, Nikolsky Y, Rakhmatulin E, Sorokina S, Ryabov A, Serebryiskaya T, Melnikov A, Metz J, Nikolskaya T. 2006. Algorithms for network analysis in systems-ADME/Tox using the MetaCore and MetaDrug platforms. Xenobiotica 36(10-11):877-901.
14. Ekins S, Nikolsky Y, Bugrim A, Kirillov E, Nikolskaya T. 2007. Pathway mapping tools for analysis of high content data. Methods Mol Biol 356:319-350.
15. Friedman RC, Farh KK, Burge CB, Bartel DP. 2009. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19(1):92-105.
16. Gamazon ER, Ziliak D, Im HK, LaCroix B, Park DS, Cox NJ, Huang RS. 2012. Genetic architecture of microRNA expression: Implications for the transcriptome and complex traits. Am J Hum Genet 90(6):1046-1063.
17. Garcia DM, Baek D, Shin C, Bell GW, Grimson A, Bartel DP. 2011. Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs. Nat Struct Mol Biol 18(10):1139-1146.
18. Gelernter J, Sherva R, Koesterer R, Almasy L, Zhao H, Kranzler HR, Farrer L. 2013. Genome-wide association study of cocaine dependence and related traits: FAM53B identified as a risk gene. Mol Psychiatry. Advance online publication, 20 August 2013; doi:10.1038/mp.2013.99 (e-pub ahead of print).
19. Giraldez AJ, Cinalli RM, Glasner ME, Enright AJ, Thomson JM, Baskerville S, Hammond SM, Bartel DP, Schier AF. 2005. MicroRNAs regulate brain morphogenesis in zebrafish. Science 308(5723):833-838.
20. Gonzalez JR, Armengol L, Sole X, Guino E, Mercader JM, Estivill X, Moreno V. 2007. SNPassoc: An R package to perform whole genome association studies. Bioinformatics 23(5):644-645.
21. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. 2007. MicroRNA targeting specificity in mammals: Determinants beyond seed pairing. Mol Cell 27(1):91-105.
22. Guo H, Ingolia NT, Weissman JS, Bartel DP. 2010. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466(7308):835-840.
23. He X, Zhang Q, Liu Y, Pan X. 2007. Cloning and identification of novel microRNAs from rat hippocampus. Acta Biochim Biophys Sin (Shanghai) 39(9):708-714.
24. Hettema JM, Neale MC, Kendler KS. 2001. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 158(10):1568-1578.
25. Hettema JM, Prescott CA, Myers JM, Neale MC, Kendler KS. 2005. The structure of genetic and environmental risk factors for anxiety disorders in men and women. Arch Gen Psychiatry 62(2):182-189.
26. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, Manolio TA. 2009. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 106(23):9362-9367.
27. Hu Z, Bruno AE. 2011. The influence of 3′UTRs on microRNA function inferred from human SNP data. Comp Funct Genomics 2011:910769.
28. Jensen KP, Covault J, Conner TS, Tennen H, Kranzler HR, Furneaux HM. 2009. A common polymorphism in serotonin receptor 1B mRNA moderates regulation by miR-96 and associates with aggressive human behaviors. Mol Psychiatry 14(4):381-389.
29. Kamakura S, Moriguchi T, Nishida E. 1999. Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases. Identification and characterization of a signaling pathway to the nucleus. J Biol Chem 274(37):26563-26571.
30. Ke X. 2012. Presence of multiple independent effects in risk loci of common complex human diseases. Am J Hum Genet 91(1):185-192.
31. Kendler KS. 1996. Major depression and generalised anxiety disorder. Same genes, (partly)different environments-Revisited. Br J Psychiatry Suppl 30:68-75.
32. Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ. 1992. Major depression and generalized anxiety disorder. Same genes, (partly) different environments? Arch Gen Psychiatry 49(9):716-722.
33. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. 2005. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62(6):617-627.
34. Kiezun A, Garimella K, Do R, Stitziel NO, Neale BM, McLaren PJ, Gupta N, Sklar P, Sullivan PF, Moran JL, Hultman CM, Lichtenstein P, Magnusson P, Lehner T, Shugart YY, Price AL, de Bakker PI, Purcell SM, Sunyaev SR. 2012. Exome sequencing and the genetic basis of complex traits. Nat Genet 44(6):623-630.
35. Kim WH, Kim BS, Kim SK, Chang SM, Lee DW, Cho MJ, Bae JN. 2012. Restless legs syndrome in older people: A community-based study on its prevalence and association with major depressive disorder in older Korean adults. Int J Geriatr Psychiatry 27(6):565-572.
36. Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M. 2005. Silencing of microRNAs in vivo with 'antagomirs'. Nature 438(7068):685-689.
37. Lee HB, Hening WA, Allen RP, Kalaydjian AE, Earley CJ, Eaton WW, Lyketsos CG. 2008. Restless legs syndrome is associated with DSM-IV major depressive disorder and panic disorder in the community. J Neuropsychiatry Clin Neurosci 20(1):101-105.
38. Lewis BP, Burge CB, Bartel DP. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120(1):15-20.
39. Lu J, Clark AG. 2012. Impact of microRNA regulation on variation in human gene expression. Genome Res 22(7):1243-1254.
40. Martin MM, Buckenberger JA, Jiang J, Malana GE, Nuovo GJ, Chotani M, Feldman DS, Schmittgen TD, Elton TS. 2007. The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microRNA-155 binding. J Biol Chem 282(33):24262-24269.
41. Martinowich K, Manji H, Lu B. 2007. New insights into BDNF function in depression and anxiety. Nat Neurosci 10(9):1089-1093.
42. Mosing MA, Gordon SD, Medland SE, Statham DJ, Nelson EC, Heath AC, Martin NG, Wray NR. 2009. Genetic and environmental influences on the co-morbidity between depression, panic disorder, agoraphobia, and social phobia: A twin study. Depress Anxiety 26(11):1004-1011.
43. Noyes R, Jr. 2001. Comorbidity in generalized anxiety disorder. Psychiatr Clin North Am 24(1):41-55.
44. Patterson N, Price AL, Reich D. 2006. Population structure and eigenanalysis. PLoS Genet 2(12):e190.
45. Pierucci-Lagha A, Gelernter J, Feinn R, Cubells JF, Pearson D, Pollastri A, Farrer L, Kranzler HR. 2005. Diagnostic reliability of the semi-structured assessment for drug dependence and alcoholism (SSADDA). Drug Alcohol Depend 80(3):303-312.
46. Pierucci-Lagha A, Gelernter J, Chan G, Arias A, Cubells JF, Farrer L, Kranzler HR. 2007. Reliability of DSM-IV diagnostic criteria using the semi-structured assessment for drug dependence and alcoholism (SSADDA). Drug Alcohol Depend 91(1):85-90.
47. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. 2006. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38(8):904-909.
48. Pritchard JK, Stephens M, Donnelly P. 2000. Inference of population structure using multilocus genotype data. Genetics 155(2):945-959.
49. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC. 2007. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81(3):559-575.
50. Richardson K, Lai CQ, Parnell LD, Lee YC, Ordovas JM. 2011. A genome-wide survey for SNPs altering microRNA seed sites identifies functional candidates in GWAS. BMC Genomics 12:504.
51. Richardson K, Nettleton JA, Rotllan N, Tanaka T, Smith CE, Lai CQ, Parnell LD, Lee YC, Lahti J, Lemaitre RN, Manichaikul A, Keller M, Mikkila V, Ngwa J, van Rooij FJ, Ballentyne CM, Borecki IB, Cupples LA, Garcia M, Hofman A, Ferrucci L, Mozaffarian D, Perala MM, Raitakari O, Tracy RP, Arnett DK, Bandinelli S, Boerwinkle E, Eriksson JG, Franco OH, Kahonen M, Nalls M, Siscovick DS, Houston DK, Psaty BM, Viikari J, Witteman JC, Goodarzi MO, Lehtimaki T, Liu Y, Zillikens MC, Chen YD, Uitterlinden AG, Rotter JI, Fernandez-Hernando C, Ordovas JM. 2013. Gain-of-function lipoprotein lipase variant rs13702 modulates lipid traits through disruption of a microRNA-410 seed site. Am J Hum Genet 92(1):5-14.
52. Roy MA, Neale MC, Pedersen NL, Mathe AA, Kendler KS. 1995. A twin study of generalized anxiety disorder and major depression. Psychol Med 25(5):1037-1049.
53. Saunders MA, Liang H, Li WH. 2007. Human polymorphism at microRNAs and microRNA target sites. Proc Natl Acad Sci USA 104(9):3300-3305.
54. Schulze TG, Detera-Wadleigh SD, Akula N, Gupta A, Kassem L, Steele J, Pearl J, Strohmaier J, Breuer R, Schwarz M, Propping P, Nothen MM, Cichon S, Schumacher J, Consortium NGIBD, Rietschel M, McMahon FJ. 2009. Two variants in Ankyrin 3 (ANK3) are independent genetic risk factors for bipolar disorder. Mol Psychiatry 14(5):487-491.
55. Sethupathy P, Borel C, Gagnebin M, Grant GR, Deutsch S, Elton TS, Hatzigeorgiou AG, Antonarakis SE. 2007. Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3' untranslated region: A mechanism for functional single-nucleotide polymorphisms related to phenotypes. Am J Hum Genet 81(2):405-413.
56. Sevim S, Dogu O, Kaleagasi H, Aral M, Metin O, Camdeviren H. 2004. Correlation of anxiety and depression symptoms in patients with restless legs syndrome: A population based survey. J Neurol Neurosurg Psychiatry 75(2):226-230.
57. Thomas LF, Saito T, Saetrom P. 2011. Inferring causative variants in microRNA target sites. Nucleic Acids Res 39(16):e109.
58. Tukel R, Polat A, Ozdemir O, Aksut D, Turksoy N. 2002. Comorbid conditions in obsessive-compulsive disorder. Compr Psychiatry 43(3):204-209.
59. Winkelman JW, Finn L, Young T. 2006. Prevalence and correlates of restless legs syndrome symptoms in the Wisconsin Sleep Cohort. Sleep Med 7(7):545-552.
60. Winkelmann J, Prager M, Lieb R, Pfister H, Spiegel B, Wittchen HU, Holsboer F, Trenkwalder C, Strohle A. 2005. " Anxietas tibiarum". Depression and anxiety disorders in patients with restless legs syndrome. J Neurol 252(1):67-71.
61. Winkelmann J, Schormair B, Lichtner P, Ripke S, Xiong L, Jalilzadeh S, Fulda S, Putz B, Eckstein G, Hauk S, Trenkwalder C, Zimprich A, Stiasny-Kolster K, Oertel W, Bachmann CG, Paulus W, Peglau I, Eisensehr I, Montplaisir J, Turecki G, Rouleau G, Gieger C, Illig T, Wichmann HE, Holsboer F, Muller-Myhsok B, Meitinger T. 2007. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet 39(8):1000-1006.
62. Winkelmann J, Czamara D, Schormair B, Knauf F, Schulte EC, Trenkwalder C, Dauvilliers Y, Polo O, Hogl B, Berger K, Fuhs A, Gross N, Stiasny-Kolster K, Oertel W, Bachmann CG, Paulus W, Xiong L, Montplaisir J, Rouleau GA, Fietze I, Vavrova J, Kemlink D, Sonka K, Nevsimalova S, Lin SC, Wszolek Z, Vilarino-Guell C, Farrer MJ, Gschliesser V, Frauscher B, Falkenstetter T, Poewe W, Allen RP, Earley CJ, Ondo WG, Le WD, Spieler D, Kaffe M, Zimprich A, Kettunen J, Perola M, Silander K, Cournu-Rebeix I, Francavilla M, Fontenille C, Fontaine B, Vodicka P, Prokisch H, Lichtner P, Peppard P, Faraco J, Mignot E, Gieger C, Illig T, Wichmann HE, Muller-Myhsok B, Meitinger T. 2011. Genome-wide association study identifies novel restless legs syndrome susceptibility loci on 2p14 and 16q12.1. PLoS Genet 7(7):e1002171.
63. Yang BZ, Zhao H, Kranzler HR, Gelernter J. 2005. Practical population group assignment with selected informative markers: Characteristics and properties of Bayesian clustering via STRUCTURE. Genet Epidemiol 28(4):302-312.